TABLE 15 (Cont'd)
Number of Deaths
Causes of Death
Percentage of Deaths from all causes
Rate per 100,000 population
1961*
1972# 1982
1961*
1972#
1982
1961* 1972#
1982
15-44 years
All causes
2,665
2,587
2,317
100.0
100.0
100.0
201.6
146.2 87.5
1.
Injury and poisoning
465
733
856
17.5
28.3
37.0
35.2
41.4 32.3
2.
Malignant neoplasms
512
649
657
19.2
25.1
28.4
38.7
36.7
24.8
3.
Heart diseases, including
246
202
143
9.2
7.8
6.1
18.6
11.4
5.4
hypertensive heart disease
4. Nephritis, nephrotic syndrome and nephrosis
75
96
98
2.8
3.7
4.2
5.7
5.4
3.7
5.
Cerebrovascular Disease
74
91
87
2.8
3.5
3.8
5.6
5.1
3.3
All other causes
1,293
816
476
48.5
31.6
20.5
97.8
46.1 18.0
45-64 years
All causes
1. Malignant neoplasms
2.
دیا
3. Cerebrovascular disease
Heart diseases, including hypertensive heart disease
4. Injury and poisoning
5,041
7,144
7,574 100.0
100.0
1,204
2,250 3,014 23.9
31.5
100.0
39.8
762 1,048
1,075 15.1
14.7
14.2
1,089.9 992.9 794.8 260.3 312.7 316.3 164.8 145.7 112.8
569
656
865 11.3
9.2
11.4
123.0
91.2 90.8
216
484
448 4.3
6.8
5.9
46.7
67.3 47.0
5.
Pneumonia, all forms
278
544
367
5.5
7.6
4.9
60.1
75.6 38.5
All other causes
2,012
2,162 1,805
39.9
30.2
23.3
435.0
300.5
189.4
TABLE 15 (Cont'd)
Number of Deaths
Percentage of Deaths
Causes of Death
from all causes
1961*
1972# 1982
1961* 1972#
1982
1961*
Rate per 100,000 population
1972#
1982
1.
65 years and over
All causes
Malignant neoplasms
4,524 9,269 14,294
2.
Heart diseases, including
100.0 100.0 100.0 503 1,392 3,069 11.1 15.0 21.5 817 1,767 2,877 18.1 19.1 20.1
4,519.5
502.5
816.2
4,790.2
3,958.5
719.4 849.9
913.2
796.7
hypertensive heart disease
3.
Cerebrovascular disease
4.
Pneumonia, all forms
5. Nephritis, nephrotic syndrome and nephrosis
747
435
88
1,127 2,235 16.5 12.2 15.6 746.3 1,208 1,467 9.6 13.0 10.3 434.6 156 502 1.9 3.5 87.9
582.4 618.9
1.7
624.3
80.6
406.3
139.0
All other causes
1,934
3,619 4,144
42.8
39.0
29.0
1,932.1
1,870.3 1,147.6
* Data regrouped according to ICD 8th Revision (1965) # Data regrouped according to ICD 9th Revision (1975)
No comments yet.
Private notes are available after approval.